August 2026– date –
-
Digital Twin Technology Accelerates Bioprocess Optimization, Enabling Real-time Monitoring and Cost Reduction
Jojo Imats (Facebook) Global Overview Digital twin technology is transforming traditional manufacturing workflows into data-driven ecosystems, monitoring every stage from design to operation in real-time. Bioprocess engineers can optimiz... -
Japan’s Regenerative Medicine Regulated by Two Pillars: Approved Cell Products and Registered Private Treatments, Emphasizing Safety and Quality
Stem Cell Clarity Japan Overview Japanese regenerative medicine is governed by two distinct legal frameworks: cell products approved by the Minister of Health, Labour and Welfare, and private treatments under a registration system where ... -
Oxford Biomedica Launches Fast-Track Viral Vector Service, Accelerating Gene Therapy Development by Cutting Manufacturing Times by up to 8 Months
Kalkine UK Overview Oxford Biomedica has launched a fast-track viral vector service to accelerate gene therapy development. This new service shortens GMP-grade manufacturing for AAV vectors from approximately 15 months to as little as 7 ... -
Azunic AI Adopts Inventia Life Science’s RASTRUM 3D Cell Culture Platform to Accelerate Human-Relevant In Vitro Toxicology
BusinessWire USA Overview Azunic AI has adopted Inventia Life Science's RASTRUM 3D cell culture platform to accelerate the development of an animal-free, human-relevant 3D in vitro toxicology platform. RASTRUM's precision bioprinting, de... -
Texas Children’s Hospital’s GMP Facility Manufactures Over 10,000 Cell Therapy Products in 20 Years, Driving CGT Innovation
Texas Children's Hospital USA Overview Texas Children's Hospital's Center for Cell and Gene Therapy (CAGT) has manufactured over 10,000 cell therapy products and more than 70 clinical-grade viral vectors over two decades, utilizing its i... -
Chemically Defined Media and Automation Key to Overcoming Raw Material Variability in Autologous Cell Therapy Manufacturing
BioProcess International USA Overview Addressing raw material variability in autologous adoptive cell therapies necessitates the adoption of chemically defined media, standardized handling, automation, and well-characterized unit operati... -
Biologics and GLP-1 Agonists Drive Acceleration of Automation and Digitization in Fill-Finish Manufacturing
BioProcess Online USA Overview The rapid rise of biologics—including antibody-drug conjugates (ADCs), cell & gene therapies, and mRNA products—and GLP-1 receptor agonists is accelerating the evolution of fill-finish manufacturing pro... -
Scire Science Launches SBIO-420 Benchtop Bioreactor, Strengthening India’s Biotech Ecosystem with Indigenous Technology
Scire Science (LinkedIn) India Overview Scire Science has announced the launch of the SBIO-420 Benchtop Magnetic Stirring Glass Bioreactor, an indigenously developed product designed to bolster India's biotechnology ecosystem. The SBIO-4... -
ENEA’s Novel Rotating Drum Bioreactor Dramatically Boosts Monoclonal Antibody Production Yields
ENEA - Agenzia nazionale (Facebook) Italy Overview Researchers at the Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA) have engineered an innovative rotating drum bioreactor that significan... -
In Vivo CAR T-Cell Therapy KLN-1010 Achieves 100% MRD Negativity in Multiple Myeloma Phase 1 Trial, Presented at ASCO/EHA 2026
International Myeloma Foundation USA Overview At the 2026 ASCO and EHA meetings, groundbreaking results for KLN-1010, an in vivo CAR T-cell therapy eliminating the need for ex vivo T-cell harvest, were highlighted. The clinical trial in ...
